Scientific Fellow, Bio-Rad Laboratories
BIOGRAPHY
Quality Control design has for many years been focused around instrument performance. But with the new risk management approaches emerging the focus is now moving to the risk of erroneous results for patients. This presentation will describe this new approach designed to prevent patient harm from erroneous results to acceptable levels.
Learning Objectives:
1. Identify the steps in patient risk managed QC strategy design.
2. Explain how to set the Severity of Harm category for an analyte.
3. Describe 2 components of the QC design that can be changed to minimize patient risk.
Resources: